In July, drug companies began recalling dozens of lots of the blood pressure and heart medications called valsartan, losartan and irbesartan after testing found the drugs had trace amounts of ...

The recalled drugs all include the blood-pressure medication valsartan, the subject of a series of recalls by several drug companies since July. The generic drug company Mylan Pharmaceuticals ...

Objectives: To assess the efficacy and tolerability of valsartan and valsartan plus hydrochlorothiazide (HCTZ), given alone or as part of a combination regimen with other antihypertensive agents ...

The US Food and Drug Administration expanded the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure.

Declines in estimated glomerular filtration rate after transition to sacubitril/valsartan for HF are mild and temporary. Clinicians should not stall or discontinue therapy due to “dips” in ...

Some of the batches aren’t due to expire until August 2020. The 104 additional lots include 26 lots of Amlodipine and Valsartan tablets, USP (including the 5mg/160mg, 10mg/160mg, 5mg/320mg ...

Valsartan (brand name Diovan), which is used to treat high blood pressure and heart failure, can be used alone or as a component of other heart medications. Last month, the FDA issued a voluntary ...

These products — with the active ingredient valsartan, a generic drug used to treat high blood pressure — may contain N-nitrosodimethylamine (NDMA), a possible human carcinogen. The FDA asked ...

In the wake of a worldwide recall, patients prescribed several common drugs that contain valsartan must be wondering exactly how much of a cancer risk their medication may have posed. Now ...

The FDA flagged concerns about valsartan, which is used to treat high blood pressure and heart failure, on July 13. Officials found traces of the chemical compound N-nitrosodimethylamine (NDMA ...